All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-36846035

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	36846035	T19I	S	S	COVID-19	G R L	View
2	36846035	A27S	S	S	COVID-19	G R L	View
3	36846035	V213G	S	S	COVID-19	G R L	View
4	36846035	G339D	S	S	COVID-19	G R L	View
5	36846035	S371F	S	S	COVID-19	G R L	View
6	36846035	S373P	S	S	COVID-19	G R L	View
7	36846035	S375F	S	S	COVID-19	G R L	View
8	36846035	T376A	S	S	COVID-19	G R L	View
9	36846035	D405N	S	S	COVID-19	G R L	View
10	36846035	R408S	S	S	COVID-19	G R L	View
11	36846035	K417N	S	S	COVID-19	G R L	View
12	36846035	N440K	S	S	COVID-19	G R L	View
13	36846035	S477N	S	S	COVID-19	G R L	View
14	36846035	E484A	S	S	COVID-19	G R L	View
15	36846035	Q493R	S	S	COVID-19	G R L	View
16	36846035	Q498R	S	S	COVID-19	G R L	View
17	36846035	Y505H	S	S	COVID-19	G R L	View
18	36846035	H655Y	S	S	COVID-19	G R L	View
19	36846035	N679K	S	S	COVID-19	G R L	View
20	36846035	N764K	S	S	COVID-19	G R L	View
21	36846035	D796Y	S	S	COVID-19	G R L	View
22	36846035	Q954H	S	S	COVID-19	G R L	View
23	36846035	N969K	S	S	COVID-19	G R L	View
24	36846035	24delL	S	S	COVID-19	G R L	View
25	36846035	25delP	S	S	COVID-19	G R L	View
26	36846035	26delP	S	S	COVID-19	G R L	View
27	36846035	D614G	S	S	COVID-19	G R L	View
28	36846035	Y453F	S	S	COVID-19	G R L	View
29	36846035	N501Y	S	S	COVID-19	G R L	View
30	36846035	P681H	S	S	COVID-19	G R L	View
31	36846035	S94F	S	S	COVID-19	G R L	View
32	36846035	A570D	S	S	COVID-19	G R L	View
33	36846035	T716I	S	S	COVID-19	G R L	View
34	36846035	S982A	S	S	COVID-19	G R L	View
35	36846035	D1118H	S	S	COVID-19	G R L	View
36	36846035	69delH	S	S	COVID-19	G R L	View
37	36846035	144delY	S	S	COVID-19	G R L	View
38	36846035	245delH	S	S	COVID-19	G R L	View
39	36846035	247delS	S	S	COVID-19	G R L	View
40	36846035	70delV	S	S	COVID-19	G R L	View
41	36846035	244delL	S	S	COVID-19	G R L	View
42	36846035	246delR	S	S	COVID-19	G R L	View
43	36846035	248delY	S	S	COVID-19	G R L	View
44	36846035	Q183R	S	S	COVID-19	G R L	View
45	36846035	K558N	S	S	COVID-19	G R L	View
46	36846035	C1236F	S	S	COVID-19	G R L	View
47	36846035	G142D	S	S	COVID-19	G R L	View
48	36846035	T478K	S	S	COVID-19	G R L	View
49	36846035	T19R	S	S	COVID-19	G R L	View
50	36846035	R158G	S	S	COVID-19	G R L	View
51	36846035	L452R	S	S	COVID-19	G R L	View
52	36846035	P681R	S	S	COVID-19	G R L	View
53	36846035	D950N	S	S	COVID-19	G R L	View
54	36846035	156delE	S	S	COVID-19	G R L	View
55	36846035	157delF	S	S	COVID-19	G R L	View
56	36846035	E96A	S	S	COVID-19	G R L	View
57	36846035	T95I	S	S	COVID-19	G R L	View
58	36846035	G181V	S	S	COVID-19	G R L	View
59	36846035	N532S	S	S	COVID-19	G R L	View
60	36846035	I850L	S	S	COVID-19	G R L	View
61	36846035	K1045N	S	S	COVID-19	G R L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.